R-Pharm Overview

  • Founded
  • 2001

Founded
  • Status
  • Private

  • Employees
  • 5,000

Employees
  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

  • Investments
  • 8

R-Pharm General Information

Description

Manufacturer and distributor of pharmaceutical products intended to serve the Russian market. The company specializes in research, development and production of pharmaceuticals, laboratory equipment and medical devices including finished dosage forms, active pharmaceutical ingredients (APIs) of chemical nature and biotechnological substances, providing affordable and efficient pharmaceutical products that improve the quality of life and increase the life expectancy of patients.

Contact Information

Website
www.r-pharm.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Leninsky Prospekt 111, k. 1
  • Moscow, 119421
  • Russia
+7 8 (000) 000-00-00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R-Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore R-Pharm‘s full profile, request access.

Request a free trial

R-Pharm Patents

R-Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3612565-A1 Anti-pd-l1 antibody and use thereof Pending 18-Apr-2017 000000000000
CA-3059447-A1 Anti-pd-l1 antibody and use thereof Pending 18-Apr-2017 000000000000
AU-2018256392-A1 Anti-pd-l1 antibody and use thereof Pending 18-Apr-2017 000000000000
EP-3612565-A4 Anti-pd-l1 antibody and use thereof Pending 18-Apr-2017 00000000000 0
JP-2020517239-A Anti-pd-l1 antibody and its use Pending 18-Apr-2017 C07K16/2827
To view R-Pharm’s complete patent history, request access »

R-Pharm Executive Team (6)

Name Title Board Seat Contact Info
Andrey Smirnov Chief Financial Officer
Oleg Rynskov Chief Information Officer
Andrey Artemov Executive Director
Mikhail Samsonov MD Chief Medical Officer
Vasily Ignatiev Ph.D Chief Executive Officer
You’re viewing 5 of 6 executive team members. Get the full list »

R-Pharm Board Members (1)

Name Representing Role Since
000000 00000 R-Pharm Founder & Chairman of the Board 000 0000
To view R-Pharm’s complete board members history, request access »

R-Pharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R-Pharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore R-Pharm‘s full profile, request access.

Request a free trial

R-Pharm Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000 11-Feb-2021 0000000000 00000 Specialty Retail 000000 00
0000 00000000 02-Dec-2020 0000000000 Buildings and Property
00 00000 0000 22-Jun-2020 00000 0000 000.00 Other Healthcare Services 000000 00
00000 0000000 10-Jun-2020 00000 0000 Drug Discovery 000000 00
Tarsa Therapeutics 01-Jan-2018 Buyout/LBO Drug Discovery
You’re viewing 5 of 8 investments and acquisitions. Get the full list »